165 related articles for article (PubMed ID: 35442415)
21. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
[TBL] [Abstract][Full Text] [Related]
22. Dysplastic nevus part I: Historical perspective, classification, and epidemiology.
Drozdowski R; Spaccarelli N; Peters MS; Grant-Kels JM
J Am Acad Dermatol; 2023 Jan; 88(1):1-10. PubMed ID: 36038073
[TBL] [Abstract][Full Text] [Related]
23. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
Roush GC; Barnhill RL
Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
[TBL] [Abstract][Full Text] [Related]
24. [Dysplastic melanocytic nevus].
Salava A; Ranki A; Saksela O
Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
[TBL] [Abstract][Full Text] [Related]
25. Incorporation of dermoscopy improves inter-observer agreement among dermatopathologists in histologic assessment of melanocytic neoplasms.
Shi K; Compres E; Walton KE; Mohan LS; Zhang B; Panah E; Quan VL; Garfield EM; Khan AU; Kim D; Yazdan P; Robinson JK; Gerami P
Arch Dermatol Res; 2021 Mar; 313(2):101-108. PubMed ID: 32338293
[TBL] [Abstract][Full Text] [Related]
26. Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model.
Vickery EL; Seidler EM; Jones TE; Veledar E; Chen SC
JAMA Dermatol; 2014 Nov; 150(11):1167-72. PubMed ID: 25028988
[TBL] [Abstract][Full Text] [Related]
27. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
28. Prediction of histologic melanocytic dysplasia from clinical observation.
Roush GC; Dubin N; Barnhill RL
J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 and D3 expression in melanocytic skin lesions.
Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
[TBL] [Abstract][Full Text] [Related]
30. Histopathologic correlation of high-risk MelaFind
Shrivastava V; Bailin P; Elliott J; Bacnik E; Gastman B; Bergfeld W; Billings SD; Piliang M; Fernandez A; Kovalyshyn I; Ko JS
Int J Dermatol; 2019 May; 58(5):569-576. PubMed ID: 30549001
[TBL] [Abstract][Full Text] [Related]
31. Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi method.
Carney PA; Reisch LM; Piepkorn MW; Barnhill RL; Elder DE; Knezevich S; Geller BM; Longton G; Elmore JG
J Cutan Pathol; 2016 Oct; 43(10):830-7. PubMed ID: 27247109
[TBL] [Abstract][Full Text] [Related]
32. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
33. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
Hastrup N; Hou-Jensen K
APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
[TBL] [Abstract][Full Text] [Related]
34. Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.
Elmore JG; Barnhill RL; Elder DE; Longton GM; Pepe MS; Reisch LM; Carney PA; Titus LJ; Nelson HD; Onega T; Tosteson ANA; Weinstock MA; Knezevich SR; Piepkorn MW
BMJ; 2017 Jun; 357():j2813. PubMed ID: 28659278
[No Abstract] [Full Text] [Related]
35. The dysplastic nevus: recognition and management.
Barnhill RL; Hurwitz S; Duray PH; Arons MS
Plast Reconstr Surg; 1988 Feb; 81(2):280-9. PubMed ID: 3275948
[TBL] [Abstract][Full Text] [Related]
36. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions?
Decarlo K; Yang S; Emley A; Wajapeyee N; Green M; Mahalingam M
Hum Pathol; 2010 Jun; 41(6):886-94. PubMed ID: 20233623
[TBL] [Abstract][Full Text] [Related]
38. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
Cockerell CJ; Berson DS
Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
[TBL] [Abstract][Full Text] [Related]
39. Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the 'gold standard'?
Braun RP; Gutkowicz-Krusin D; Rabinovitz H; Cognetta A; Hofmann-Wellenhof R; Ahlgrimm-Siess V; Polsky D; Oliviero M; Kolm I; Googe P; King R; Prieto VG; French L; Marghoob A; Mihm M
Dermatology; 2012; 224(1):51-8. PubMed ID: 22433231
[TBL] [Abstract][Full Text] [Related]
40. Biopsy diagnoses of clinically atypical pigmented lesions of the head and neck in adults.
Udovenko O; Griffin JR; Elston DM
Am J Dermatopathol; 2014 Oct; 36(10):829-31. PubMed ID: 25247672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
